UltraSight

UltraSight

HealthMedical Imaging AIB2B📍 Rehovot, Israel

UltraSight is an Israeli medtech startup that has developed an AI-based platform enabling trained medical staff to perform echocardiograms. The platform aims to address the shortage of cardiac imaging specialists by allowing hospitals to expand access to cardiac imaging without relying solely on specialized sonographers. This funding will support the expansion of its commercial operations and implementation within U.S. healthcare systems.

Visit website ↗
Total raised
Undisclosed
tracked to date
Latest round
Series B2
Sep 23, 2026
Known investors
8
led by Alive HealthTech Growth Fund
Press coverage
2
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups in Israel.

Claim this profile →

Funding history

  1. 1
    $24 millionSeries B2Sep 23, 2026

    Led by Alive HealthTech Growth Fund

    Announcement ↗

Founder

Itay Kezurer
Itay Kezurer
CTO

Investors in UltraSight

Backers from this company's tracked funding rounds.

  • AAlive HealthTech Growth FundLead investorVC firm
  • DDeep InsightVC firm
  • SStar51 CapitalVC firm
  • CConnecticut InnovationsVC firm
  • EeHealth VenturesVC firm
  • MMayo Clinic VenturesVC firm
  • NNYUVC firm
  • IIron NationVC firm

UltraSight in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile